Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • rebrendi
    ng
    • May 2008
    • 78

    MACS output format (NAME_peaks.bed)

    Hi all,

    I am analyzing a ChIP-Seq output file with TF enrichment peaks from the published dataset. It looks like the data are in the MACS output format. The files are named "NAME_peaks.bed" and the content looks like this:

    chr1 2011287 2011686 . 34 +

    I guess the columns, left to right, are the chromosome name, peak start, peak end, the last one is the strand, but I don't know what is in between. Do you have any ideas what is in the 4th-5th columns? Also, do you have any ideas why the distance between the start and end is so large, and how one would extract the transcription factor binding site location from this broad peak?

    Thanks!
    Last edited by rebrendi; 03-27-2012, 07:29 AM.
  • dpryan
    Devon Ryan
    • Jul 2011
    • 3478

    #2
    It's a BED file, so just read the spec. From the MACS readme file, the 5th column is the "-10*log10pvalue of peak region".

    Comment

    • rebrendi
      ng
      • May 2008
      • 78

      #3
      dpryan, thank you.

      concerning my second question: is it safe to assume that the TF binding site is located in the middle of the identified broad peak (start+end)/2 ?

      Comment

      • dpryan
        Devon Ryan
        • Jul 2011
        • 3478

        #4
        I wouldn't assume that. You could use something like meme for motif discovery.

        Comment

        • rebrendi
          ng
          • May 2008
          • 78

          #5
          dpryan, I am not looking for motifs, just need the coordinates for each TF binding site (assuming that each peak contains one binding site). There is no single consensus motif for this TF, that is known. Do you think there is a simple way to use these peak.bed files to detect the coordinates of the binding sites?

          Comment

          • mudshark
            Senior Member
            • Jan 2009
            • 138

            #6
            basic question: you sure your file is a MACS output file?

            Comment

            • rebrendi
              ng
              • May 2008
              • 78

              #7
              Originally posted by mudshark View Post
              basic question: you sure your file is a MACS output file?
              nope. it is provided as is by the authors

              Comment

              • mudshark
                Senior Member
                • Jan 2009
                • 138

                #8
                so it has been published, any description on how the peak calling was performed? did you ask the authors?
                are the raw data also published? maybe you better do the peak calling yourself then

                Comment

                • rebrendi
                  ng
                  • May 2008
                  • 78

                  #9
                  Originally posted by mudshark View Post
                  so it has been published, any description on how the peak calling was performed? did you ask the authors?
                  are the raw data also published? maybe you better do the peak calling yourself then
                  you are right, have to contact the authors...
                  Last edited by rebrendi; 03-27-2012, 07:31 AM.

                  Comment

                  • anurag.gautam
                    Member
                    • Oct 2010
                    • 15

                    #10
                    HI,
                    Once we are done with identifying the peaks for chip seq data, how can we validate those results in wetlab. Since these all are bioinformatics predictions, are there any techniques other than PCR to validate the peaks we called??

                    Comment

                    • mudshark
                      Senior Member
                      • Jan 2009
                      • 138

                      #11
                      that all depends on your target, model organism etc etc.
                      reporter gen assays are probably most straight forward in any case.

                      Comment

                      Latest Articles

                      Collapse

                      • SEQadmin2
                        Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
                        by SEQadmin2


                        Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

                        The systematic characterization of the human proteome has
                        ...
                        07-20-2026, 11:48 AM
                      • SEQadmin2
                        Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
                        by SEQadmin2



                        Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
                        ...
                        07-09-2026, 11:10 AM
                      • SEQadmin2
                        Cancer Drug Resistance: The Lingering Barrier to Rising Survival
                        by SEQadmin2



                        Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

                        There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
                        07-08-2026, 05:17 AM

                      ad_right_rmr

                      Collapse

                      News

                      Collapse

                      Topics Statistics Last Post
                      Started by SEQadmin2, 07-24-2026, 12:17 PM
                      0 responses
                      29 views
                      0 reactions
                      Last Post SEQadmin2  
                      Started by SEQadmin2, 07-23-2026, 11:41 AM
                      0 responses
                      21 views
                      0 reactions
                      Last Post SEQadmin2  
                      Started by SEQadmin2, 07-20-2026, 11:10 AM
                      0 responses
                      211 views
                      0 reactions
                      Last Post SEQadmin2  
                      Started by SEQadmin2, 07-13-2026, 10:26 AM
                      0 responses
                      78 views
                      0 reactions
                      Last Post SEQadmin2  
                      Working...